Study guide

11.5 Single-Ventricle Physiology & Staged Palliation

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

11.5 Single-Ventricle Physiology & Staged Palliation

Key Takeaways Explain This Topic AI

In single-ventricle physiology, one pumping chamber supplies pulmonary and systemic beds in parallel. Gas exchange, systemic oxygen delivery, perfusion, and Qp/Qs trends are interpreted together; no saturation alone proves balanced flow.

The three-stage surgical palliation pathway consists of: Stage 1 Norwood with modified Blalock-Taussig shunt or Sano conduit (neonate), Stage 2 Bidirectional Glenn or Hemi-Fontan (4 to 6 months), and Stage 3 Fontan completion, sometimes with a fenestration (often around 2 to 4 years).

Unexpectedly rising saturation accompanied by falling pressure, oliguria, lactate elevation, or poor perfusion can signal pulmonary overcirculation and systemic steal. Escalate to the congenital-cardiac team rather than applying a universal CO2, oxygen, or PEEP recipe.

Last updated: September 2026

11.5 Single-Ventricle Physiology & Staged Palliation

Single-ventricle congenital cardiac anomalies—most notably Hypoplastic Left Heart Syndrome (HLHS)—present the most complex cardiopulmonary physiology encountered in neonatal and pediatric critical care. In these patients, a single morphological ventricle must simultaneously support both the systemic and pulmonary circulations operating in parallel. Blood distribution is strongly influenced by pulmonary and systemic resistance, but also by anatomic obstruction, shunt or conduit characteristics, ventricular function, valve function, preload, hemoglobin, and ventilation. Gas changes can be clinically important and should be interpreted in that larger hemodynamic picture. The Neonatal/Pediatric Specialist must master single-ventricle surgical staging, the hemodynamics of systemic steal, subambient gas blending, invasive pressure interpretation, and advanced noninvasive regional oximetry.

Single-Ventricle Anatomy: Hypoplastic Left Heart Syndrome (HLHS)

Hypoplastic Left Heart Syndrome encompasses a spectrum of severe underdevelopment of left-sided cardiac structures:

Pathological Components: Severe hypoplasia or atresia of the aortic valve, mitral valve, ascending aorta, and left ventricle. The ascending aorta is frequently a diminutive "hypoplastic string" ( 1 to 2 mm 1\text{ to }2\text{ mm} 1 to 2 mm in diameter) that serves merely as a retrograde conduit to supply the coronary arteries.

Obligate Parallel Circulation: Oxygenated blood returning to the left atrium cannot enter the hypoplastic left ventricle; it must traverse an obligate interatrial communication (PFO/ASD) to mix with deoxygenated systemic venous blood in the right atrium. The morphologic Right Ventricle (RV) serves as the single pumping chamber, ejecting the mixed stroke volume into the main pulmonary artery. From the pulmonary artery, blood travels either to the lungs via the pulmonary arteries or to the body via a widely patent ductus arteriosus (PDA) into the descending aorta. PARALLEL SINGLE-VENTRICLE CIRCULATION

  • │
  • [Morphologic Right Ventricle]
  • (Single Pump: Qtotal)
  • │
  • ┌────────────────────┴────────────────────┐
  • ▼ ▼
  • [Pulmonary Bed: Qp] [Systemic Organs: Qs]
  • (Governed by PVR) (Governed by SVR)
  • │ │
  • └────────────────────┬────────────────────┘
  • ▼
  • [Common Mixing: Right Atrium]

Because both circulations are supplied from a common ventricular output:

Q total = Q p + Q s Q_{\text{total}} = Q_p + Q_s Q total ​ = Q p ​ + Q s ​

The SVR-to-PVR relationship is a useful conceptual guide to flow distribution, but measured Q p / Q s Q_p/Q_s Q p ​ / Q s ​ is not simply equal to S V R / P V R SVR/PVR S V R / P V R because anatomy, shunt resistance, ventricular function, and pressure gradients also matter.

The Three-Stage Surgical Palliation Pathway

HLHS cannot be converted into a normal two-ventricle circulation in most patients. Management pathways include staged single-ventricle palliation, transplantation in selected cases, and individualized goals-of-care decisions.

Stage 1: Norwood Procedure (with mBT Shunt or Sano Conduit)

Timing: Performed during the first week of life (days 3–7) .

Three Surgical Goals:

Neo-Aorta Reconstruction: The main pulmonary artery is transected and anastomosed to the diminutive hypoplastic ascending aorta and aortic arch, creating a large, unified systemic outflow tract from the right ventricle.

Unrestricted Atrial Septectomy: Complete excision of the atrial septum to ensure completely unobstructed egress of oxygenated pulmonary venous blood from the left atrium into the right atrium.

Regulated Pulmonary Blood Flow Source: Because the main pulmonary artery is now the neo-aorta, a new source of pulmonary blood flow is established using one of two techniques:

Modified Blalock-Taussig (mBT) Shunt: A synthetic PTFE (Gore-Tex) tube (typically 3.0 to 3.5 mm 3.0\text{ to }3.5\text{ mm} 3.0 to 3.5 mm ) connecting the right subclavian or innominate artery to the right pulmonary artery. Advantage: Simple to place. Disadvantage: Generates continuous diastolic runoff from the aorta into the pulmonary bed, lowering diastolic blood pressure and compromising coronary artery perfusion pressure.

Sano Conduit (RV-to-PA Conduit): A conduit from the right ventricle to the pulmonary arteries provides the pulmonary source. Compared with an mBT shunt it generally reduces aortopulmonary diastolic runoff, but it requires a ventriculotomy and does not guarantee superior coronary perfusion or outcome.

Stage 2: Bidirectional Glenn / Hemi-Fontan Procedure

Timing: Commonly performed around 3 to 6 months , after PVR has fallen sufficiently and when anatomy, growth, oxygenation, ventricular function, and center strategy support proceeding.

Surgical Execution: The prior systemic-to-pulmonary shunt (BT shunt or Sano conduit) is taken down. The Superior Vena Cava (SVC) is transected and anastomosed directly to the right pulmonary artery (end-to-side).

Physiological Impact: Venous blood from the head and upper body reaches the pulmonary arteries without a subpulmonary ventricle, reducing single-ventricle volume load. Expected saturation and pressure are patient- and pathway-specific; obstruction, elevated PVR, collateral flow, lung disease, and ventricular dysfunction can impair the result.

Stage 3: Fontan Completion Procedure

Timing: Performed at 2 to 4 years of age 2\text{ to }4\text{ years of age} 2 to 4 years of age .

Surgical Execution: The Inferior Vena Cava (IVC) is routed directly to the pulmonary artery via an extracardiac synthetic conduit (Gore-Tex) or an intra-atrial lateral tunnel.

Fenestration when used: A small surgically created communication between the Fontan pathway and atrium. This acts as a safety pop-off: if PVR spikes post-operatively, blood shunts right-to-left into the atrium, preserving left-sided filling and cardiac output at the cost of mild desaturation.

Result: Total cavopulmonary connection. All systemic venous blood flows passively through the pulmonary capillary bed driven entirely by central venous pressure (transpulmonary gradient: CVP − LAP \text{CVP} - \text{LAP} CVP − LAP ). The single ventricle pumps exclusively oxygenated arterial blood to the systemic circulation.

The Trap of "Excessive Oxygenation" & Systemic Steal

In unpalliated single-ventricle neonates and Stage 1 Norwood patients, the balance between pulmonary blood flow ( Q p Q_p Q p ​ ) and systemic blood flow ( Q s Q_s Q s ​ ) is fragile. Excessive pulmonary flow can reduce effective systemic flow and requires prompt recognition. PULMONARY OVERCIRCULATION AND SYSTEMIC FLOW

  • │
  • [Trigger: Oxygen above need or unintended hyperventilation in susceptible physiology]
  • │
  • ▼
  • [Pulmonary vasodilation may lower PVR]
  • │
  • ▼
  • [Pulmonary flow may rise relative to systemic flow]
  • │
  • ┌─────────────────────┴─────────────────────┐
  • ▼ ▼
  • [PULMONARY VASCULAR BED] [SYSTEMIC VASCULAR BED]
  • Pulmonary congestion may worsen • Effective systemic flow may fall
  • Work of breathing may rise • Pulses/perfusion may deteriorate
  • Lung compliance may fall • Urine output may decline
  • Saturation can rise despite poorer DO2 • Lactate/metabolic acidosis may rise
  • Clinical Presentation of Systemic Steal

The Oximetry Paradox: A rising saturation may accompany excessive pulmonary flow while systemic perfusion deteriorates. Saturation cannot by itself calculate Qp/Qs; interpret it with arterial and venous oxygen content, hemoglobin, lactate, pressure, urine output, NIRS trends, and echocardiography.

Systemic Collapse: The infant develops mottled, cool extremities, delayed capillary refill ( > 3 to 4 seconds >3\text{ to }4\text{ seconds} > 3 to 4 seconds ), diminished or absent femoral pulses, profound oliguria ( < 0.5 mL/kg/hr <0.5\text{ mL/kg/hr} < 0.5 mL/kg/hr ), acute mesenteric ischemia, necrotizing enterocolitis, and severe lactic metabolic acidosis.

The Target Saturation Rule

To maintain an optimal balance where Q p / Q s ≈ 1.0 Q_p/Q_s \approx 1.0 Q p ​ / Q s ​ ≈ 1.0 :

Typical monitored range: Many Stage 1 pathways accept SpO2 around 75%–85%, but the prescribed range is patient- and center-specific. Interpret it with lactate, blood pressure, urine output, near-infrared spectroscopy, venous saturation, and echocardiography.

PaO2 and SpO2: Follow the congenital-cardiac team's target for that anatomy and stage. A saturation above the prescribed range warrants prompt perfusion assessment, but it does not by itself diagnose systemic steal or define an emergency.